| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 7e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.19 | 8e-06 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.22 | 0.0002 |